Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization [Phase 3]
A Phase 3 trial comparing transarterial chemoembolization with stereotactic body radiation therapy or stereotactic ablative radiation therap…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant [Phase 2]
A Phase 2 trial comparing SBRT versus TACE as a bridge to liver transplantation for hepatocellular carcinoma has completed with results post…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for intravenous T3011 as a single agent and in combination therapy in advanced solid tumors including hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients [Phase 2]
Phase 2 clinical trial update evaluating Tace with Icaritin as first-line treatment for middle and advanced hepatocellular carcinoma in Chil…
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating modified TOMOX-HAIC with sintilimab and a bevacizumab biosimilar as first-line therapy for advanced hepatocellula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma [Phase 3]
A Phase 3 trial comparing Transarterial Chemoembolization (TACE) plus sorafenib versus TACE alone in recurrent intermediate hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE [Phase 4]
A Phase 4 trial comparing oxycodone and sufentanil for pain and inflammatory response after transarterial chemoembolization in hepatocellula…
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update for GT90001 plus nivolumab in advanced hepatocellular carcinoma (HCC).
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC [Phase 1, Phase 2]
Clinical trial update on lenvatinib plus tislelizumab with or without TACE as first-line treatment for unresectable hepatocellular carcinoma…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC) [Phase 1, Phase 2]
Clinical trial update on the combination of GT90001 with nivolumab in metastatic hepatocellular carcinoma (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC [Phase 3]
A Phase 3 trial evaluating SHR-1210 in combination with Apatinib as first-line therapy for advanced hepatocellular carcinoma has completed w…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma [Phase 2, Phase 3]
Clinical trial update comparing SCT-I10A plus SCT510 to sorafenib as first-line therapy for advanced hepatocellular carcinoma (PHASE 2/3).
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC [Phase 3]
Phase 3 trial evaluating aprepitant plus granisetron and dexamethasone for preventing vomiting in patients undergoing hepatic arterial infus…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC [Phase 3]
Phase 3 trial assessing adjuvant entecavir or tenofovir after surgery for HBV-related hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation [Phase 3]
A Phase 3 trial evaluating adjuvant tislelizumab plus lenvatinib for patients at high risk of hepatocellular carcinoma recurrence after cura…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC [Phase 2, Phase 3]
Phase 2/3 trial update evaluating hepatectomy combined with camrelizumab and apatinib in CNLC stage IIIb hepatocellular carcinoma is ongoing…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP) [Phase 3]
Phase 3 trial of apatinib after systemic therapy in hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: MRI Only Radiation Therapy With CPAP [NA]
A terminated clinical trial studying MRI-only radiation therapy with CPAP for liver and pancreatic carcinoma; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies [Phase 1, Phase 2]
Early-phase study of CB-103 in adults with various advanced solid tumors and hematologic malignancies has been terminated; results were post…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy [Phase 2]
Phase 2 clinical trial evaluating adoptive autologous iNKT cells for progressed hepatocellular carcinoma in patients continuing PD-1 inhibit…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC [Phase 1, Phase 2]
Early-phase trial investigating cadonilimab in combination with regorafenib for advanced hepatocellular carcinoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial [Phase 3]
A Phase 3 randomized, double-blind trial evaluating FOLFOX-HAIC plus lenvatinib and toripalimab versus FOLFOX-HAIC plus lenvatinib in advanc…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma [Phase 2]
Phase II trial evaluating concurrent sorafenib with IMRT for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors [Phase 1, Phase 2]
Clinical trial update for KD6001 in combination with anti-PD-1 antibody with or without bevacizumab in advanced hepatocellular carcinoma and…
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC [Phase 2]
Phase 2 single-arm trial evaluating HAIC with apatinib and camrelizumab in unresectable macrotrabecular massive hepatocellular carcinoma.